Bharat Biotech gets go-ahead to conduct Phase-III trials of Covaxin

The around 28,500 people expected to enrol for the Phase-III trials would be given two doses of the investigational vaccineThe around 28,500 people expected to enrol for the Phase-III trials would be given two doses of the investigational vaccineRead More